Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
106.27
-0.10 (-0.09%)
At close: Sep 16, 2025, 4:00 PM EDT
106.20
-0.07 (-0.07%)
After-hours: Sep 16, 2025, 4:41 PM EDT
Verona Pharma Market Cap
Verona Pharma has a market cap or net worth of $9.16 billion as of September 16, 2025. Its market cap has increased by 319.01% in one year.
Market Cap
9.16B
Enterprise Value
8.97B
1-Year Change
319.01%
Ranking
Category
Stock Price
$106.27
Market Cap Chart
Since April 27, 2017, Verona Pharma's market cap has increased from $173.40M to $9.16B, an increase of 5,182.37%. That is a compound annual growth rate of 60.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 9.17B | 141.26% |
| Dec 31, 2024 | 3.80B | 139.13% |
| Dec 29, 2023 | 1.59B | -19.57% |
| Dec 30, 2022 | 1.98B | 389.96% |
| Dec 31, 2021 | 403.30M | 33.68% |
| Dec 31, 2020 | 301.70M | 298.55% |
| Dec 31, 2019 | 75.70M | -40.25% |
| Dec 31, 2018 | 126.70M | -16.92% |
| Dec 29, 2017 | 152.50M | -12.05% |
| Apr 27, 2017 | 173.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |